{
"id":"mk19_bb_gi_s30",
"subspecialtyId":"gi",
"title":"Primary Sclerosing Cholangitis",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gi_s30",
"title":{
"__html":"Primary Sclerosing Cholangitis"
},
"titleNode":{
"type":"section-title",
"hlId":"e5d02e",
"children":[
"Primary Sclerosing Cholangitis"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gi_s30_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"56c460",
"children":[
{
"type":"abbreviation",
"title":"primary sclerosing cholangitis",
"children":[
"PSC"
]
},
" is a chronic cholestatic liver disease of unknown cause characterized by progressive bile duct destruction and biliary cirrhosis. ",
{
"type":"alert",
"children":[
"About 85% of patients have ",
{
"type":"abbreviation",
"title":"inflammatory bowel disease",
"children":[
"IBD"
]
},
" (most often ulcerative colitis)."
]
},
" Characteristic findings are:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"f3dbbf",
"children":[
"pruritus or jaundice"
]
},
" ",
{
"type":"list-item",
"hlId":"745eed",
"children":[
"elevated serum alkaline phosphatase level"
]
},
" ",
{
"type":"list-item",
"hlId":"8fcfd3",
"children":[
"elevated total bilirubin level"
]
},
" ",
{
"type":"list-item",
"hlId":"e89d74",
"children":[
"modestly elevated ",
{
"type":"abbreviation",
"title":"aspartate aminotransferase",
"children":[
"AST"
]
},
" and ",
{
"type":"abbreviation",
"title":"alanine aminotransferase",
"children":[
"ALT"
]
},
" levels"
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gi_s30_2",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"60a021",
"children":[
{
"type":"abbreviation",
"title":"magnetic resonance cholangiopancreatography",
"children":[
"MRCP"
]
},
" establishes the diagnosis (look for the “string of beads” pattern)."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_gi_f08"
],
"forceOpen":true
}
]
},
{
"type":"section",
"id":"mk19_bb_gi_s30_3",
"title":{
"__html":"Follow-up Surveillance"
},
"titleNode":{
"type":"section-title",
"hlId":"3af103",
"children":[
"Follow-up Surveillance"
]
},
"children":[
{
"type":"p",
"hlId":"9f9a1e",
"children":[
"Patients with PSC are at risk for developing cholangiocarcinoma as well as gallbladder carcinoma and colon cancer (when associated with IBD). ",
{
"type":"alert",
"children":[
"Screen for colon cancer with colonoscopy every 1-2 years beginning at diagnosis of PSC, regardless of patient age or duration or extent of the IBD."
]
}
]
},
{
"type":"p",
"hlId":"0e0e8f",
"children":[
"Annual MRCP and carbohydrate 19-9 level measurement are recommended for cholangiocarcinoma surveillance."
]
},
{
"type":"p",
"hlId":"ec4340",
"children":[
"Patients with cirrhosis require screening for ",
{
"type":"abbreviation",
"title":"hepatocellular carcinoma",
"children":[
"HCC"
]
},
" with ultrasonography every 6 months."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gi_s30_4",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"ab1625",
"children":[
"Liver transplantation is the only effective treatment."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gi_s30_5",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"e0962e",
"class":"test",
"children":[
"A 45-year-old man with a 15-year history of ulcerative colitis develops fatigue and pruritus. Serum alkaline phosphatase level is 750 U/L, AST is 48 U/L, ALT is 60 U/L, and total bilirubin is 2.0 mg/dL."
]
},
{
"type":"p",
"hlId":"e2bc64",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose PSC. For management, select MRCP and colonoscopy for colorectal cancer screening."
]
}
]
}
]
},
"tablesContent":{
}
}